Skip to main content
. 2025 May 22;6(1):273–281. doi: 10.1089/pmr.2024.0097

Table 1.

Characteristic of Study Population (N = 5855)

Characteristics Number (n) Percent (%)
Gender    
 Male 3230 55.2
 Female 2625 44.8
Age of death in years (median age 69 ± SD 14)    
 0–17 20 0.3
 18–34 75 1.3
 35–64 1872 32.0
 65–74 1691 28.9
 75–84 1487 25.4
 ≥85 710 12.1
Primary cancer prior to first therapy    
 Yes 545 9.3
 No 5310 90.7
Recurrent cancer    
 Yes 1930 33.1
 No 3917 66.9
Metastasis    
 Yes 2830 48.3
 No 3025 51.7
Malignant neoplasms    
 Solid tumors 5355 91.5
 Hematological malignancies 500 8.5
Primary diagnosis    
 C00–C14 Malignant neoplasms of lip, oral cavity, and pharynx 490 8.4
 C15–C26 Malignant neoplasms of digestive organs 1826 31.2
 C30–C39 Malignant neoplasms of respiratory and intrathoracic organs 637 10.9
 C43 Malignant melanoma of skin 306 5.2
 C50 Malignant neoplasm of breast 641 10.9
 C51–C58 Malignant neoplasms of female genital organs 373 6.4
 C60–C63 Malignant neoplasms of male genital organs 357 6.1
 C64–C68 Malignant neoplasms of urinary tract 367 6.3
 C69–C72 Malignant neoplasms of eye, brain, and other parts of central nervous system 358 6.1
 C81–C96 Malignant neoplasms of lymphoid, hematopoietic, and related tissue 500 8.5
Duration from diagnosis until death in months    
 0–12 1946 33.2
 >12 3909 66.8
Contact with specialized palliative care unit within 30 days before death    
 No 5202 88.8
 Yes 653 11.2

SD, standard deviation.